October was an interesting month. Prior to that the market was very narrow, led by large-cap tech stocks.
But in October, the (market-cap weighted) S&P 500 was down about 1%. But the equal-weight index was actually up almost 5%. Quite a gap in performance. That tells her that the breadth is broadening, stock in sectors other than large tech are doing quite well.
So there was a rotation in the market. Investors didn't necessarily sell the market. They just rotated away from tech and semiconductors toward healthcare and even utilities. Toward things that are more defensive.
That's encouraging. Historically, a bull market is healthier if it's more broad-based.
Exactly. A lot of the industrial names that supply the data centre buildout have pulled back on fears that the buildout will slow, product demand won't be as great, and profits will suffer.
Pullback is healthy, as a lot of those names were trading at very high multiples.
Peaked out in July, now 45% off highs. The classic cyclical. Data centre buildout will change this to secular growth. Pulled back when pace of AI buildout came into question.
Multiple's now more reasonable, ~22x forward PE. Huge backlog, no cancellations so far. Will generate a lot of FCF. If demand fades, earnings will eventually roll over.
Feeling impact of lower- and middle-income consumer; value menu tweaks will take time. Traffic is soft. US economy is K-shaped. Helping frachisees upgrade restaurants. Sees room to grow its chicken market, but equipment needs to be retooled.
Still likes it. Economies of scale, synergies, gets rent from many franchisees (a recurring cashflow stream).
Diagnostic testing that did so well during Covid declined, and other segments weren't strong enough to offset that. Largely behind them, but now issues in nutrition business.
Lawsuits regarding infant formula, many being settled out of court. Plans to spin off that segment next year.
Good pipeline, M&A continues. Valuation's pulled back. Yield is 2%.